Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Pathol Res Pract ; 213(9): 1097-1101, 2017 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-28778496

RESUMEN

Peri-implantitis is an infectious disease characterized by inflammation of the tissues surrounding the implant, bleeding on probing with or without suppuration, and bone loss. Peri-implant lesions contain a leukocyte infiltrate of plasma cells, lymphocytes, macrophages and neutrophils. A survey of the literature did not show any studies reporting an association between hypoxia and peri-implantitis. The aim of the present cross-sectional study was to evaluate histological changes and immunostaining for CD15, CD57 and HIF-1α in the peri-implant mucosa of patients with and without peri-implantitis. Mucosal biopsies were obtained from 18 patients with peri-implantitis and 10 control subjects without peri-implantitis at a private health care center between 2010 and 2012. The sections were fixed in 10% buffered formalin, processed and embedded in paraffin for histopathological and immunohistochemical study. Acanthosis, spongiosis and exocytosis were observed in both groups, with no significant difference between them. The peri-implantitis group showed increased immunostaining for CD15, a neutrophil marker, and HIF-1α, a tissue hypoxia marker, but no significant difference in immunostaining for CD57, a Natural Killer cell marker. The increase in neutrophil (CD15) and hypoxia (HIF-1α) markers in patients with peri-implantitis suggests an active participation of neutrophils and hypoxia in the pathogenesis of this disease. Since the present study was the first to evaluate the expression of CD15, CD57 and HIF-1α in peri-implant tissues, further studies should be performed to better understand the role of these molecules in peri-implantitis.


Asunto(s)
Implantes Dentales/efectos adversos , Periimplantitis/inmunología , Estomatitis/inmunología , Anciano , Biomarcadores/análisis , Biopsia , Antígenos CD57/análisis , Antígenos CD57/biosíntesis , Estudios Transversales , Femenino , Fucosiltransferasas/análisis , Fucosiltransferasas/biosíntesis , Humanos , Subunidad alfa del Factor 1 Inducible por Hipoxia/análisis , Subunidad alfa del Factor 1 Inducible por Hipoxia/biosíntesis , Antígeno Lewis X/análisis , Antígeno Lewis X/biosíntesis , Masculino , Persona de Mediana Edad
2.
Med Oral Patol Oral Cir Bucal ; 17(1): e63-8, 2012 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-22157667

RESUMEN

OBJECTIVE: The aim of this work was to evaluate the expression of FUT2 gene in saliva and histo ABH antigens of patients with oral lesions. STUDY DESIGN: In total 178 subjects were examined, half of whom suffered from oral pre-cancerous and cancerous lesions, while the other half were the healthy control group We analyzed the FUT 2 polymorphism by ASO-PCR (allele specific oligonucleotid - polymerase chain reaction) with specific primers for G428 allele and the wild type allele of FUT2 gene. To reveal A, B and H antigens in tissue sections of the patients (n= 89) we used a modified specific red cell adherence technique. RESULTS: We found a high intensity of oral disease in the non-secretor group (OR = 2.43). A total of 58% of the patients with oral pre-cancerous and cancerous lesions was non secretors (se_/_), in contrast with the healthy population (21.5%). A strongly positive reaction was defined as a sheet of indicator erythrocytes adhered to the epithelial cells. In 31 of the 54 samples analyzed the test showed slightly positive results on atypical areas, and there was a complete antigen deletion in areas affected by neoplasia. Nineteen samples showed a total absence of ABH antigens in both histologically normal and pathological areas. Blood group antigens were expressed at a high level in benign and highly differentiated malignant tumors. In poorly differentiated malignant tumors, they were mostly absent. CONCLUSION: Considering these results we suggest the use of this method to monitor probable preneoplastic lesions in risk population, especially in those with no secretor status (absence of FUT2 gene).


Asunto(s)
Sistema del Grupo Sanguíneo ABO/biosíntesis , Fucosiltransferasas/biosíntesis , Neoplasias de la Boca/sangre , Lesiones Precancerosas/sangre , Fucosiltransferasas/análisis , Expresión Génica , Humanos , Neoplasias de la Boca/genética , Lesiones Precancerosas/genética , Saliva/química , Galactósido 2-alfa-L-Fucosiltransferasa
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA